SUNNYVALE, Calif. and WASHINGTON, May 16, 2011 /PRNewswire/ -- The American Urological Association (AUA) Meeting, May 16, 2011 -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it will showcase the CyberKnife® Robotic Radiosurgery System, used to treat more than 6,500 prostate cancer patients around the world to date, in the company's booth (#3243) at the American Urological Association (AUA) meeting. Accuray will also sponsor a theater presentation on use of the CyberKnife System for prostate cancer, highlighting published long-term data on outcomes and the important role of multidisciplinary teams in treating prostate cancer patients with SBRT. The AUA meeting takes place May 14-17, 2011 in Washington, D.C.
"Recently published five-year data on CyberKnife SBRT for prostate cancer validates the long-term efficacy of prostate SBRT," said Omar Dawood, vice president, medical affairs, Accuray. "This adds to the growing body of clinical evidence in support of the CyberKnife System for prostate cancer. The unique capabilities of our robotic technology to track and correct for prostate movement has helped Accuray solidify our position as a leader in the field of prostate SBRT. In the first quarter of calendar year 2011, we achieved a 20 percent increase in worldwide prostate cancer treatments as compared to the same period last year and look forward to continued wide adoption of this non surgical treatment option."